Marta Lustig, M.Sc.
Facts
E-Mail:
Marta.Lustig[at]uksh.de
Affiliations:
Division of Stem Cell Transplantation and Immunotherapy / University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Rosalind-Franklin-Str. 12, 24105 Kiel
Supervisor:
Prof. Dr. med. Thomas Valerius
Curriculum vitae
Education/Training
| Since 09/2020 | PhD candidate at the Division of Stem Cell Transplantation and Immunotherapy, University Medical Center Schleswig Holstein Kiel, (Germany) “Improving myeloid cell activation by therapeutic monoclonal antibodies” |
| 10/2019-06/2020 | Master’s thesis at the Department of Internal Medicine II, Hematology and Oncology, Division of Stem Cell Transplantation and Immunotherapy, University Medical Center Schleswig Holstein Kiel, (Germany) “Inhibition of sialic acid-Siglec interactions improves myeloid cell activation by therapeutic monoclonal antibodies” |
| 12/2018-02/2019 | Student Research Assistant at Molecular Imaging North Competence Centre Kiel (MOIN CC) (Germany) |
| 10/2016-02/2017 06/2017-09/2017 | Bachelor’s thesis at the Centre of Advanced Biotechnology, Laboratory of Biotherapy at the San Martino Policlinic Hospital, Cancer Research, Genoa (Italy) “Potential role of ROBO1 in uveal melanoma progression” |
| 02/2017-06/2017 | Erasmus+ Traineeship Program at the Institute of Biochemistry, Faculty of Medicine, Leipzig University, Leipzig (Germany) |
Research Experience/Academic Appointments
| 2018-2020 | Master of Science – Medical Life Sciences Faculty of Medicine, Kiel University (Germany) |
| 2014-2017 | Bachelor of Science – Biotechnology Faculty of Biotechnology, University of Genoa (Italy) |
Research groups
Project-related publications
P6
PREPRINT: Antibody-lectin chimeras for glyco-immune checkpoint blockade
bioRxiv - preprint
2022